Chief Operating Officer of PTC THERAPEUTICS, INC. (U.S.: Nasdaq:PTCT), Klein Matthew B., sells 775 shares worth $29,857
According to PTC THERAPEUTICS, INC.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 11 04:18 PM, company Chief Operating Officer, Klein Matthew B. disclosed selling 775 shares at a cost of $38.52. At the time of this transaction (Jan 07), this trade was worth $29,857 in total. As of Jan 07, Klein Matthew B. now owns 16,461 shares in total worth about $667,328.94.
For the last few recent trades made by PTC THERAPEUTICS, INC. (U.S.: Nasdaq:PTCT) Chief Operating Officer, Klein Matthew B., we have the following information:
- SEC Form 4 filing: Apr 19: Sold 859 shares at the rate of $48.17 per share. Total worth of this trade was $41,376. Total number of shares owned as of Apr 19 were 18,450
- SEC Form 4 filing: Apr 20: Sold 1,641 shares at the rate of $46.74 per share. Total worth of this trade was $76,704. Total number of shares owned as of Apr 20 were 16,809
- SEC Form 4 filing: Jan 15: Sold 4,300 shares at the rate of $69.09 per share. Total worth of this trade was $297,078. Total number of shares owned as of Jan 15 were 19,309
Posted by
George Daniels
on Tuesday January 11 2022, 11:00 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
